Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Morphosys AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

30 Apr 2016 Reuters Investment Profile 12 $20.00

MorphoSys AG (MOR) - Financial Analysis Review

MorphoSys AG (MOR) - Financial Analysis Review Summary MorphoSys AG (Morphosys) develops monoclonal antibodies for therapeuti...

19 Apr 2016 GlobalData 80 $300.00

Wright Investors Service Comprehensive Report for MorphoSys AG

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

04 Apr 2016 Wright Reports 56 $75.00

MorphoSys AG: Upgraded to Good

22 Mar 2016 Sadif Analytics Prime 3 $10.00

MorphoSys AG (MOR) - Financial Analysis Review

MorphoSys AG (MOR) - Financial Analysis Review Summary MorphoSys AG (Morphosys) develops monoclonal antibodies for therapeuti...

17 Mar 2016 GlobalData 79 $300.00

MORG.DE - Event Transcript of Morphosys AG conference call, Mar. 02, 2016 / 8:00AM ET

Edited Event Transcript of MORG.DE conference call, Mar. 02, 2016 / 8:00AM ET Boston, Mar 2, 2016 (Thomson StreetEvents...

02 Mar 2016 Thomson Reuters StreetEvents 19 $75.00

Will MorphoSys AG Continue its Slide?

11 Feb 2016 Sadif Analytics Prime 12 $25.00

MorphoSys AG: Downgraded to Above Average

21 Dec 2015 Sadif Analytics Prime 3 $10.00

MORPHOSYS - MOR208 AND MOR202 DATA AT ASH

At the American Society of Hematology (ASH) annual meeting, compelling early combination data on MOR208 and MOR202 were prese...

17 Dec 2015 Edison Investment Research 8 $10.00

MorphoSys AG (MOR) - Financial Analysis Review

MorphoSys AG (MOR) - Financial Analysis Review Summary MorphoSys AG (Morphosys) develops monoclonal antibodies for therapeuti...

16 Dec 2015 GlobalData 83 $300.00